Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-06-19
1999-09-07
Lee, Howard C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 3, 514 53, 514 61, 514866, A61K 3828, A61K 3170
Patent
active
059487518
ABSTRACT:
Insulin preparations of superior physical stability, comprising dissolved and/or precipitated human insulin or an analogue or derivative thereof, and a water-soluble reduced or non-reducing carbohydrate containing at least 4 carbon atoms in the main carbohydrate structure, or a water-soluble non-reducing ester and/or ether derivative of a carbohydrate or reduced carbohydrate containing at least 4 carbon atoms in the main carbohydrate structure, or mixtures thereof are disclosed.
REFERENCES:
patent: 4439181 (1984-03-01), Blackshear et al.
patent: 4839341 (1989-06-01), Massey et al.
patent: 4876241 (1989-10-01), Feldman et al.
patent: 5149777 (1992-09-01), Hansen et al.
patent: 5164366 (1992-11-01), Balschmidt et al.
patent: 5430016 (1995-07-01), Balschmidt et al.
patent: 5514646 (1996-05-01), Chance et al.
patent: 5622934 (1997-04-01), Frick et al.
patent: 5693609 (1997-12-01), Baker et al.
patent: 5705482 (1998-01-01), Christensen et al.
Gupta and Bhat "Effect of solvent additives on the thermal stability of insulin" Center for Biotechnology, New Delhi pp. 209-212.
Balschmidt Per
Jensen Steen
Kimer Lone L.o slashed.gstrup
Esq. Reza Green
Lee Howard C.
Novo Nordisk A S
Zelson Esq. Steve T.
LandOfFree
X14-mannitol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with X14-mannitol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and X14-mannitol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1804554